Publications by authors named "Steffen Wedel"

Claim this Profile
T
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
Christopher C Parker, Robert E Coleman, Oliver Sartor, Nicholas J Vogelzang, David Bottomley, Steffen Wedel

Eur Urol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.
Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, Kurt Miller, Wolfgang Schultze-Seemann, Steffen Wedel

J Immunother Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prostate cancer - androgen deprivation: intermittent or continuous?].
Steffen A Wedel

Aktuelle Urol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer.
Paweł Wiechno, Bradley G Somer, Begoña Mellado, Piotr L Chłosta, José Manuel Cervera Grau, Steffen Wedel

Eur Urol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.
Lukasz Hudak, Patrick Tezeeh, Steffen Wedel, Jasmina Makarević, Eva Juengel

Prostate· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancer.
Steffen A Wedel, Ivaylo N Raditchev, Jon Jones, Eva Juengel, Tobias Engl

Mol Med Rep· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokines involved in tumor promotion and dissemination in patients with renal cell cancer.
Igor Tsaur, Anika Noack, Ana Maria Waaga-Gasser, Jasmina Makarevic, Lars Schmitt, Steffen Wedel

Cancer Biomark· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.
Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, Jasmina Makarević, Eva Juengel

BMC Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.
Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, Jasmina Makarević, Eva Juengel

Clin Exp Metastasis· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical analysis of simultaneous blockage of histone deacetylase and multiple receptor tyrosine kinase in the treatment of prostate cancer.
Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, Eva Juengel, Elsie Oppermann

Prostate· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.
Kai Doberstein, Anja Wieland, Sophia B Boyoung Lee, Roman A Alexander Blaheta, Steffen Wedel

Carcinogenesis· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells.
Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, Eva Juengel, Igor Tsaur

Cancer Lett· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effects of the HDAC inhibitor valproic acid on prostate cancer growth are enhanced by simultaneous application of the mTOR inhibitor RAD001.
Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, Eva Juengel, Igor Tsaur

Life Sci· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of intravesical tumor location with metastases to the pelvic lymph nodes in transitional cell cancer of the bladder.
Steffen Alexander Wedel, Jon Jones, Igor Tsaur, Hanns Ackermann, Wolf-Dietrich Beecken

Am J Med Sci· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo.
Jon Jones, Eva Juengel, Ausra Mickuckyte, Lukasz Hudak, Steffen Wedel

J Cell Mol Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrix.
Jon Jones, Eva Juengel, Ausra Mickuckyte, Lukasz Hudak, Steffen Wedel

J Cell Mol Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
Jon Jones, Wassilios Bentas, Roman A Blaheta, Jasmina Makarevic, Lukasz Hudak, Steffen Wedel

Int J Mol Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autocrine stimulation of human hepatocytes triggers late DNA synthesis and stabilizes long-term differentiation in vitro.
Kerstin Leckel, Christoph Strey, Wolf O Bechstein, Kim A Boost, Marcus K H Auth, Steffen Wedel

Int J Mol Med· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
Jon Jones, Dana Marian, Eva Weich, Tobias Engl, Steffen Wedel

Exp Cell Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranes.
Jon Jones, Stefan Berkhoff, Eva Weich, Tobias Engl, Steffen Wedel

J Cell Mol Med· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis